Immunome (IMNM) EBT Margin (2023 - 2025)
Immunome (IMNM) reported EBT Margin of 1157.61% for Q2 2025, up 53482.0% on a YoY basis from N/an in Q2 2024, and up 24.12% quarter-over-quarter from 1525.5% in Q1 2025.
Immunome (IMNM) EBT Margin (2023 - 2025) Analysis & Trends
Immunome has reported EBT Margin for 3 years, with the latest figure at 1157.61% in Q2 2025.
- For the quarter ending Q2 2025, EBT Margin rose 53482.0% year-over-year to 1157.61%; the trailing twelve-month figure through Mar 2026 stood at 5947.9% (down 395359.0% YoY), and the FY2025 full-year result was 3228.83%, up 15354.0% from the prior year.
- EBT Margin for Q2 2025 stood at 1157.61%, up from 1525.5% in the prior quarter.
- The five-year high for EBT Margin was 129.96% in Q3 2023, with the low at 12857.05% in Q1 2024.
- Historically, EBT Margin has averaged 2492.75% across 3 years, with a median of 1608.96% in 2025.
- Annual changes were most pronounced in 2024 — EBT Margin plunged 1266792 bps — and 2025, when it surged 1133155 bps.
- Immunome's EBT Margin stood at 2473.94% in 2023, then decreased by 22 bps to 3030.31% in 2024, then soared by 62 bps to 1157.61% in 2025.
- The last three EBT Margin figures came in at 1157.61% (Q2 2025), 1525.5% (Q1 2025), and 3030.31% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,157.61% |
| Mar 31, 2025 | -1,525.50% |
| Dec 31, 2024 | -3,030.31% |
| Sep 30, 2024 | -1,736.15% |
| Jun 30, 2024 | -1,692.43% |
| Mar 31, 2024 | -12,857.05% |
| Dec 31, 2023 | -2,473.94% |
| Sep 30, 2023 | -129.96% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -189.13% |